Olaparib, a new hope for ovarian cancer

被引：0
|
作者：
Samoon, Zarka [1 ]
Jabbar, Adnan Abdul [1 ]
机构：
[1] Aga Khan Univ Hosp, Dept Oncol, Karachi, Pakistan
来源：
INDIAN JOURNAL OF CANCER | 2020年 / 57卷 / 03期
关键词：
MAINTENANCE THERAPY; PHASE-2; PARP;
D O I：
10.4103/ijc.IJC_1_19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [1] Olaparib in the treatment of ovarian cancer
    Washington, Christina R.
    Richardson, Debra L.
    Moore, Kathleen N.
    FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
  • [2] OLAPARIB FOR THE TREATMENT OF OVARIAN CANCER
    Bornstein, E.
    Jimeno, A.
    DRUGS OF TODAY, 2016, 52 (01) : 17 - 28
  • [3] New Biologic Frontiers in Ovarian Cancer: Olaparib and PARP Inhibition
    Dalton, Heather J.
    Coleman, Robert L.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (05) : 5 - 12
  • [4] Olaparib for the treatment of epithelial ovarian cancer
    McLachlan, Jennifer
    Banerjee, Susana
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 995 - 1003
  • [5] Olaparib in ovarian cancer with BRCA mutation
    Pujade-Lauraine, Eric
    Combe, Pierre
    BULLETIN DU CANCER, 2015, 102 (06) : S82 - S84
  • [6] Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
    Maiorano, Brigida Anna
    Maiorano, Mauro Francesco Pio
    Maiello, Evaristo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Profile of olaparib in the treatment of advanced ovarian cancer
    Chase, Dana M.
    Patel, Shreya
    Shields, Kristin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 125 - 129
  • [8] Safety evaluation of olaparib for treating ovarian cancer
    Lheureux, Stephanie
    Bowering, Valerie
    Karakasis, Katherine
    Oza, Amit M.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1305 - 1316
  • [9] The use of Ctrough for the therapeutic drug monitoring of olaparib in patients with ovarian cancer
    Stanislawiak-rudowicz, J.
    Szalek, E.
    Grzebalska, M.
    Urjasz, H.
    Michalak, M.
    Madry, R.
    Grzeskowiak, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (24) : 9426 - 9436
  • [10] Experience with the use of olaparib in patients with ovarian cancer
    Gallardo-Rincon, Dolores
    Alamilla-Garcia, Gabriela
    Montes-Servin, Edgar
    Morales-Vazquez, Flavia
    Cano-Blanco, Claudia
    Coronel-Martinez, Jaime
    Bahena-Gonzalez, Antonio
    Gerson-Cwilich, Raquel
    Isla-Ortiz, David
    Toledo-Leyva, Alfredo
    Montes-Servin, Elizabeth
    Michel-Tello, David
    Espinosa-Romero, Raquel
    GACETA MEDICA DE MEXICO, 2019, 155 (06): : 585 - 589
12345